Baebies, Inc.

Durham, NC 27709

SBIR Award Summary

Total Number of Awards 13
Total Value of Awards $7.17MM
First Award Date 04/01/14
Most Recent Award Date 09/01/17

Key Personnel

Last Name Name Awards Contact
PAMULA VAMSEE K PAMULA 9
NORTON SCOTT MICHAEL NORTON 3
SINGH RAJENDRA SINGH 1

13 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-13-090
Budget: 09/01/17 - 08/31/18

ABSTRACT Multiplex Platform for Point-of-Care Newborn Screening of Hyperbilirubinemia (PAR-13-090) Neonatal jaundice is a frequent condition which, when unmonitored or untreated, can lead to severe neonatal hyperbilirubinemia (HBR) and associated morbidities. Following guidelines set by the American Academy of Pediatrics, most babies in the U.S...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 08/15/17 - 07/31/18

ABSTRACT Thyroid dysfunction is among the most common morbidities of the neonatal period and can result in permanent cognitive disability and other serious complications if not rapidly identified and treated. While newborn thyroid screening in state public health laboratories has revolutionized the identification of children with severe congenit...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 08/15/17 - 07/31/18

We aim to revolutionize the traditional newborn screening paradigm by developing a point-of-care digital microfluidic platform for biochemical screening of fatty acid oxidation disorders (FAOs) and galactosemia. These disorders are inborn errors of metabolism that have profound neurological and hypoglycemic effects if not detected early. Althoug...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HL-14-011
Budget: 07/01/17 - 06/30/18

ABSTRACT Digital Microfluidics ? Minimizing blood volume for pediatric coagulation screening (HL125484) It is reported that up to 20% of neonates undergoing cardiac surgery suffer a major thrombosis event. Mortality related to pediatric stroke, pulmonary embolism, or thrombosis in patients undergoing cardiac surgery may be as high as 10%. In ad...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 07/01/17 - 06/30/18

ABSTRACT Rapid, Near Patient Nucleic Acid Testing for Congenital Cytomegalovirus (CMV) Infection PA-14-088 (Direct to Phase II) Universal newborn hearing screening is mandated in the United States and is performed in the postpartum hospital setting. Current physiology-based hearing tests are unable to detect late-onset infantile hearing loss c...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 04/10/17 - 03/31/18

ABSTRACT Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns using Low Blood Volume (Fast-Track SBIR) Hypoglycemia is the most common metabolic disorder in newborns and places the neonate at increased risk of seizures and permanent brain injury. The etiology of severe neonatal hypoglycemia -- which affects around 25,000 ne...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/16/16 - 08/31/17

? DESCRIPTION (provided by applicant): Point-of-birth newborn screening for MCAD/VLCAD and galactosemia to eliminate deadly delays for time critical conditions (PA-15-269) We aim to revolutionize the traditional newborn screening paradigm by developing a point-of-care digital microfluidic platform for biochemical screening of fatty acid oxi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-13-090
Budget: 09/16/16 - 08/31/17

ABSTRACT Multiplex Platform for Point-of-Care Newborn Screening of Hyperbilirubinemia (PAR-13-090) Neonatal jaundice is a frequent condition which, when unmonitored or untreated, can lead to severe neonatal hyperbilirubinemia (HBR) and associated morbidities. Following guidelines set by the American Academy of Pediatrics, most babies in the U.S...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HL-14-011
Budget: 09/01/16 - 06/30/17

ABSTRACT Digital Microfluidics ? Minimizing blood volume for pediatric coagulation screening (HL125484) It is reported that up to 20% of neonates undergoing cardiac surgery suffer a major thrombosis event. Mortality related to pediatric stroke, pulmonary embolism, or thrombosis in patients undergoing cardiac surgery may be as high as 10%. In ad...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HL-14-026
Budget: 09/15/14 - 08/31/15

DESCRIPTION (provided by applicant): It is reported that up to 40% of neonates undergoing cardiac surgery suffer a major thrombosis event. Pediatric patients who are at increased risk for thrombosis due to either congenital or acquired hypercoagulability require individualized anticoagulation management. Presence of a thrombophilia influences c...

Load More